Officer Singh Prahlad R. covered exercise/tax liability with 3,421 shares, was granted 26,796 shares, exercised 25,525 shares at a strike of $92.09 and sold $2,557,859 worth of shares (25,525 units at $100.21), increasing direct ownership by 24% to 120,213 units (SEC Form 4)
$RVTY
Biotechnology: Laboratory Analytical Instruments
Industrials
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
|
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | ||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
REVVITY, INC. [ RVTY ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 02/04/2026 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 02/04/2026 | F | 3,421(1)(2) | D | $101.13 | 93,417 | D | |||
| Common Stock | 02/04/2026 | A | 26,796(3) | A | $0 | 120,213 | D | |||
| Common Stock | 02/05/2026 | M | 25,525 | A | $92.09 | 145,738 | D | |||
| Common Stock | 02/05/2026 | S(4) | 1,307 | D | $99.02(5) | 144,431 | D | |||
| Common Stock | 02/05/2026 | S(4) | 12,186 | D | $99.55(6) | 132,245 | D | |||
| Common Stock | 02/05/2026 | S(4) | 7,885 | D | $100.63(7) | 124,360 | D | |||
| Common Stock | 02/05/2026 | S(4) | 3,079 | D | $101.45(8) | 121,281 | D | |||
| Common Stock | 02/05/2026 | S(4) | 1,068 | D | $102.52(9) | 120,213 | D | |||
| Common Stock | 46,583 | I | By Singh Family Trust of 2021(10) | |||||||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| NQ Stock Option (right to buy) | $103.395 | 02/04/2026 | A | 76,647 | (11) | 02/04/2033 | Common Stock | 76,647 | $0 | 76,647 | D | ||||
| NQ Stock Option (right to buy) | $92.09 | 02/05/2026 | M | 25,525 | (12) | 02/05/2026 | Common Stock | 25,525 | $0 | 0 | D | ||||
| Explanation of Responses: |
| 1. The vesting schedule for the restricted stock unit grant to the Reporting Person included in the Form 4 filed on February 6, 2025 was incorrectly reported due to administrative error. The restricted stock unit grant included in that Form 4 is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. |
| 2. These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 4, 2025, as required by the Reporting Person's Restricted Stock Unit Agreement. |
| 3. Shares are time-based restricted stock units that are scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. |
| 4. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 6, 2025. |
| 5. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $98.98 to $99.07. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $99.10 to $100.08. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $100.10 to $101.09. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 8. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $101.12 to $101.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 9. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $102.18 to $103.03. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 10. Securities held in an irrevocable trust for the sole benefit of the Reporting Person's children. The Reporting Person's spouse is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| 11. This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. |
| 12. This option became exercisable in three equal annual installments beginning on February 5, 2020, which was the first anniversary of the date on which the option was granted. |
| Remarks: |
| President, Chief Executive Officer and Director |
| John L. Healy (POA on file) for Prahlad R. Singh | 02/06/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||